- The authors reply: Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions
-
Matz EL, Pearlman A, Terlecki R
- KMID: 2414763
- Investig Clin Urol.
- 2018 Jul;59(4):282-282.
- doi: 10.4111/icu.2018.59.4.282
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Infection following penile prosthesis placement at an academic training center remains low despite involvement of surgeons-in-training
-
McAbee KE, Pearlman A, Terlecki R
- KMID: 2419418
- Investig Clin Urol.
- 2018 Sep;59(5):342-347.
- doi: 10.4111/icu.2018.59.5.342
PURPOSE: Primary care providers harbor misconceptions regarding penile prosthetic surgery, largely overestimating the rate of infection. Rates of infection following surgery for primary placement and revision are estimated as 1%... -
- CITED
-
- Close
- SHARE
-
- Close
- An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh
-
Sandberg J, Gray I, Pearlman A, Terlecki R
- KMID: 2404982
- Investig Clin Urol.
- 2018 Mar;59(2):126-132.
- doi: 10.4111/icu.2018.59.2.126
PURPOSE: To assess the utility of the Manufacturer And User Facility Device Experience (MAUDE) database in objectively capturing adverse events for transvaginal mesh in the United States. MATERIALS AND METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Proof of concept: Exposing the myth of urethral atrophy after artificial urinary sphincter via assessment of circumferential recovery after capsulotomy and intraoperative pressure profiling of the pressure regulating balloon
-
Pearlman A, Rasper AM, Terlecki R
- KMID: 2414761
- Investig Clin Urol.
- 2018 Jul;59(4):275-279.
- doi: 10.4111/icu.2018.59.4.275
PURPOSE: Rate of continence after artificial urinary sphincter (AUS) placement appears to decline with time. After appropriate workup to exclude inadvertent device deactivation, development of urge or overflow incontinence, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions
-
Matz EL, Pearlman A, Terlecki R
- KMID: 2399267
- Investig Clin Urol.
- 2018 Jan;59(1):61-65.
- doi: 10.4111/icu.2018.59.1.61
PURPOSE: Autologous platelet rich plasma (PRP) is used increasingly in a variety of settings. PRP injections have been used for decades to improve angiogenesis and wound healing. They have also... -
- CITED
-
- Close
- SHARE
-
- Close
